Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.30 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.30 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.30 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.30 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6166110 | 0.88 | HTT (0.34) | HTT | |
| SCHEMBL6167888 | 0.86 | HTT (0.39) | HTTCSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL6168175 | 0.85 | CSNK2A2 (0.33) | CSNK2A2CSNK2BCSNK2A1CSNK2A3ABCG2 | |
| SCHEMBL6167101 | 0.82 | HTT (0.56) | HTT | |
| SCHEMBL6165665 | 0.80 | ALPL (0.39) | HTT | |
| SCHEMBL6165102 | 0.78 | HTT (0.41) | HTTCSNK2A2CSNK2BCSNK2A1ABCG2 | |
| SCHEMBL6163497 | 0.77 | HTT (0.40) | HTTCSNK2A2CSNK2BCSNK2A1ABCG2 | |
| SCHEMBL6164263 | 0.76 | HTT (0.41) | HTTCSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL6772625 | 0.74 | CSNK2A2 (0.34) | CSNK2A2CSNK2BCSNK2A1CSNK2A3ABCG2 | |
| SCHEMBL6166699 | 0.74 | HTT (0.61) | HTTCSNK2A2CSNK2BCSNK2A1CSNK2A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1177185-B1 | 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS | PHARMACIA ITALIA SPA (IT) | 2005-04-20 | — | — | EP | disclosed |
| US-6716856-B1 | CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY | PHARMACIA & TUBJOHN SPA (IT) | 2004-04-06 | — | — | US | disclosed |
| EP-1177185-A1 | 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS | PHARMACIA & UPJOHN S.p.A. (IT) | 2002-02-06 | — | — | EP | disclosed |
| WO-2000069846-A1 | 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS | PHARMACIA & UPJOHN S.P.A. (IT) | 2000-11-23 | — | — | WO | disclosed |